EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Asparagusofficinalis potentially supports cancer care: a systematic review of randomized and non-randomized clinical studies

Chen Shen, Xiao-Ti Wu, Xue-Feng Wang, Zhi-Jie Wang, Zi-Yu Tian, Nicola Robinson, Jian-Ping Liu

Frontiers in Nutrition · 12.03.2026 · 13

DOI: 10.3389/fnut.2026.1621710 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Nutrition, online erschienen am 12.03.2026. Verfasst von Chen Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate effectiveness and safety of Asparagus officinalis in cancer care.

Methods

PubMed, the Cochrane Library, EMBASE, Web of Science, Scopus and four Chinese databases were searched up to January 9, 2025. Randomized and non-randomized clinical studies, cohort studies, or case-control studies were included for cancer patients using A. officinalis products alone or combined with conventional treatments. Primary outcomes were survival, response rates, and quality of life (QoL). GRADE approach was used to assess evidence certainty.

Results

Ten studies (seven randomized trials, two non-randomized studies, one cohort study) with 8,898 participants were included. Compared to chemotherapy alone, A. officinalis granules plus chemotherapy improved survival-based effective rate [two studies, risk ratio (RR) 1.55, 95% confidence interval (CI) (1.24, 1.92), low certainty] and QoL-based effective rate [three studies, RR 1.76, 95% CI (1.47, 2.11), low certainty]. The objective response rate (ORR) was improved when chemotherapy was combined with either A. officinalis granules or syrup [four studies, RR 1.88, 95% CI (1.43, 2.48), low certainty]. A. officinalis products (syrup, granules or oral liquid) plus chemotherapy or radiotherapy, all found to have effects in improving immune function as CD4 and CD4/CD8. A. officinalis oral liquid combined with chemotherapy was associated with fewer adverse events, nausea and vomiting, and myelosuppression.

Conclusion

A. officinalis products may improve survival, ORR, QoL and immune function as a complementary add-on therapy. Despite the limited number of studies and low certainty of evidence, the observed signals indicate a need for verification in well-designed, cancer-type–specific trials, particularly in lung cancer, using standardized, well-characterized extracts to establish definitive clinical applications and dosing protocols.

Systematic review registration

The review protocol was registered with the International Prospective Register of Systematic Reviews ( PROSPERO , CRD42025646003).

Schlagwörter

Stichwörter der Autor:innen

Asparagaceaeadjuvant therapybioactive compoundscancer careintegrative oncologyquality of lifesurvivalvegetable

Autor:innen und Institutionen

  • Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
  • The Oncology Department, Shanxi Hospital of Traditional Chinese Medicine, Taiyuan, China.
  • Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China.
  • Institute of Health and Social Care, London South Bank University, London, United Kingdom.
  • Center for Evidence-Based Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Zitieren

APA

Shen, C., Wu, X. T., Wang, X. F., Wang, Z. J., Tian, Z. Y., Robinson, N., & Liu, J. P. (2026). Asparagusofficinalis potentially supports cancer care: a systematic review of randomized and non-randomized clinical studies. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1621710

Vancouver

Shen C, Wu XT, Wang XF, Wang ZJ, Tian ZY, Robinson N, et al. Asparagusofficinalis potentially supports cancer care: a systematic review of randomized and non-randomized clinical studies. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1621710

BibTeX
@article{Shen2026,
  author = {Shen, Chen and Wu, Xiao-Ti and Wang, Xue-Feng and Wang, Zhi-Jie and Tian, Zi-Yu and Robinson, Nicola and Liu, Jian-Ping},
  title = {Asparagusofficinalis potentially supports cancer care: a systematic review of randomized and non-randomized clinical studies},
  journal = {Frontiers in Nutrition},
  year = {2026},
  volume = {13},
  doi = {10.3389/fnut.2026.1621710}
}
Kostenlos starten →